1. Home
  2. ARCT vs GHI Comparison

ARCT vs GHI Comparison

Compare ARCT & GHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arcturus Therapeutics Holdings Inc.

ARCT

Arcturus Therapeutics Holdings Inc.

HOLD

Current Price

$7.31

Market Cap

192.6M

Sector

Health Care

ML Signal

HOLD

Logo Greystone Housing Impact Investors LP Beneficial Unit Certificates representing assignments of limited partnership interests

GHI

Greystone Housing Impact Investors LP Beneficial Unit Certificates representing assignments of limited partnership interests

HOLD

Current Price

$8.00

Market Cap

161.5M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARCT
GHI
Founded
2013
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Finance: Consumer Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
192.6M
161.5M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
ARCT
GHI
Price
$7.31
$8.00
Analyst Decision
Buy
Strong Buy
Analyst Count
11
4
Target Price
$38.44
$13.00
AVG Volume (30 Days)
601.4K
195.5K
Earning Date
03-05-2026
02-19-2026
Dividend Yield
N/A
18.57%
EPS Growth
N/A
N/A
EPS
N/A
0.17
Revenue
$97,601,000.00
$26,247,399.00
Revenue This Year
N/A
$201.02
Revenue Next Year
N/A
$2.87
P/E Ratio
N/A
$47.24
Revenue Growth
N/A
N/A
52 Week Low
$5.85
$6.01
52 Week High
$24.17
$13.29

Technical Indicators

Market Signals
Indicator
ARCT
GHI
Relative Strength Index (RSI) 53.32 64.90
Support Level $7.42 $7.28
Resistance Level $7.82 $7.75
Average True Range (ATR) 0.33 0.36
MACD 0.21 0.11
Stochastic Oscillator 68.15 96.75

Price Performance

Historical Comparison
ARCT
GHI

About ARCT Arcturus Therapeutics Holdings Inc.

Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases. It operates in one business segment, which includes all activities related to the discovery, development, and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC and LUNAR-CF. Its Vaccine candidates include LUNAR-FLU, KOSTAIVE XBB.1.5, KOSTAIVE, and Others.

About GHI Greystone Housing Impact Investors LP Beneficial Unit Certificates representing assignments of limited partnership interests

Greystone Housing Impact Investors LP engaged in acquiring a portfolio of mortgage revenue bonds (MRBs) that are issued by state and local housing authorities to provide construction and/or permanent financing for affordable multifamily housing, seniors housing, and commercial properties. It has four reportable segments, namely Affordable Multifamily MRB Investments, Seniors and Skilled Nursing MRB Investments, MF Properties, and Market-Rate Joint Venture Investments. It generates the majority of its revenue from the Affordable Multifamily MRB Investments segment.

Share on Social Networks: